+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

COPD Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • ID: 5005251
  • Report
  • January 2020
  • Region: Global
  • 220 pages
  • Transparency Market Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • Cipla Inc.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • MORE
COPD Drug Delivery Devices Market - Scope of the Report

This report on the global COPD drug delivery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2019 to 2027. The report provides the overall market revenue of the global COPD drug delivery devices market for the period of 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global COPD drug delivery devices market from 2019 to 2027.

The report has been prepared after an extensive research. Primary research involves bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global COPD drug delivery devices market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global COPD drug delivery devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global COPD drug delivery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global COPD drug delivery devices market.

The report delves into the competitive landscape of the global COPD drug delivery devices market. Key players operating in the global COPD drug delivery devices market have been identified and each one of them has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global COPD drug delivery devices market that have been profiled in this report.

Key Questions Answered
  • What is the sales/revenue generated by COPD drug delivery devices market across all regions during the forecast period?
  • What are the opportunities in the global COPD drug delivery devices market?
  • What are the major drivers, restraints, opportunities, and threats in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which product segment is expected to generate the highest revenue globally in 2027? Which segment is projected expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Research Objectives and Research Approach

The comprehensive report on the global COPD drug delivery devices market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global COPD drug delivery devices market in terms of product, type, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2027 has been provided herein. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global COPD drug delivery devices market.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • Cipla Inc.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • MORE

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global COPD Drug Delivery Devices Market

4. Market Overview
4.1.  Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global COPD Drug Delivery Devices Market Analysis and Forecast, 2017–2027

5. Key Insights
5.1. Disease Prevalence in Key Countries
5.2. Key Market Events
5.3. Regulatory Scenario

6. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
6.3.1. Inhaler
6.3.1.1. Metered Dose Inhaler
6.3.1.2. Dry Powder Inhaler
6.3.1.3. Soft Mist Inhaler
6.3.2. Nebulizer
6.3.2.1. Jet Nebulizer
6.3.2.2. Mesh Nebulizer
6.3.2.3. Ultrasonic Nebulizer
6.4. Global COPD Drug Delivery Devices Market Attractiveness, by Product

7. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global COPD Drug Delivery Devices Market Value (US$) Forecast, by Type, 2017–2027
7.3.1. Manual Device
7.3.2. Digital Device
7.4. Global COPD Drug Delivery Devices Market Attractiveness, by Type

8. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Global COPD Drug Delivery Devices Market Attractiveness, by Distribution Channel

9. Global COPD Drug Delivery Devices Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global COPD Drug Delivery Devices Market Attractiveness, by Region

10. North America COPD Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.2. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
10.2.1. Inhaler
10.2.1.1. Metered Dose Inhaler
10.2.1.2. Dry Powder Inhaler
10.2.1.3. Soft Mist Inhaler
10.2.2. Nebulizer
10.2.2.1. Jet Nebulizer
10.2.2.2. Mesh Nebulizer
10.2.2.3. Ultrasonic Nebulizer
10.3. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
10.3.1. Manual Device
10.3.2. Digital Device
10.4. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America COPD Drug Delivery Devices Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Type
10.6.3. By Distribution Channel
10.6.4. By Country

11. Europe COPD Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.2. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
11.2.1. Inhaler
11.2.1.1. Metered Dose Inhaler
11.2.1.2. Dry Powder Inhaler
11.2.1.3. Soft Mist Inhaler
11.2.2. Nebulizer
11.2.2.1. Jet Nebulizer
11.2.2.2. Mesh Nebulizer
11.2.2.3. Ultrasonic Nebulizer
11.3. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
11.3.1. Manual Device
11.3.2. Digital Device
11.4. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe COPD Drug Delivery Devices Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region

12. Asia Pacific COPD Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
12.2.1. Inhaler
12.2.1.1. Metered Dose Inhaler
12.2.1.2. Dry Powder Inhaler
12.2.1.3. Soft Mist Inhaler
12.2.2. Nebulizer
12.2.2.1. Jet Nebulizer
12.2.2.2. Mesh Nebulizer
12.2.2.3. Ultrasonic Nebulizer
12.3. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
12.3.1. Manual Device
12.3.2. Digital Device
12.4. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region

13. Latin America COPD Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.2. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
13.2.1. Inhaler
13.2.1.1. Metered Dose Inhaler
13.2.1.2. Dry Powder Inhaler
13.2.1.3. Soft Mist Inhaler
13.2.2. Nebulizer
13.2.2.1. Jet Nebulizer
13.2.2.2. Mesh Nebulizer
13.2.2.3. Ultrasonic Nebulizer
13.3. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
13.3.1. Manual Device
13.3.2. Digital Device
13.4. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America COPD Drug Delivery Devices Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region

14. Middle East & Africa COPD Drug Delivery Devices Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
14.2.1. Inhaler
14.2.1.1. Metered Dose Inhaler
14.2.1.2. Dry Powder Inhaler
14.2.1.3. Soft Mist Inhaler
14.2.2. Nebulizer
14.2.2.1. Jet Nebulizer
14.2.2.2. Mesh Nebulizer
14.2.2.3. Ultrasonic Nebulizer
14.3. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
14.3.1. Manual Device
14.3.2. Digital Device
14.4. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6. Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Type
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region

15. Competition Landscape
15.1. Competition Matrix
15.2. Market Share Analysis, by Company (2018)
15.3. Company Profiles
15.3.1. AstraZeneca
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Boehringer Ingelheim GmbH
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. GlaxoSmithKline plc
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Novartis AG
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. Teva Pharmaceutical Industries
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Merck & Co., Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Cipla Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Sunovion Pharmaceuticals, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Koninklijke Philips N.V.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. PARI GmbH
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Growth Strategies
15.3.10.3. SWOT Analysis
15.3.11. Omron Corporation
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Company Financials
15.3.11.3. Growth Strategies
15.3.11.4. SWOT Analysis

List of Tables

Table 01: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global COPD Drug Delivery Devices Market, by Inhaler, 2017–2027
Table 03: Global COPD Drug Delivery Devices Market, by Nebulizer, 2017–2027
Table 04: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 05: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 06: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 08: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027
Table 09: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027
Table 10: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 11: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 12: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 13: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 14: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027
Table 15: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027
Table 16: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 17: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 18: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 19: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 20: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027
Table 21: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027
Table 22: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 23: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 24: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 25: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 26: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027
Table 27: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027
Table 28: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 29: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 30: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 31: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 32: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Inhaler, 2017–2027
Table 33: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Nebulizer, 2017–2027
Table 34: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 35: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 36: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figures

Figure 01: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Global COPD Drug Delivery Devices Market Value Share, by Product, 2018
Figure 03: Global COPD Drug Delivery Devices Market Value Share, by Type, 2018
Figure 04: Global COPD Drug Delivery Devices Market Value Share, by Distribution Channel, 2018
Figure 05: Global COPD Drug Delivery Devices Market Value Share, by Region, 2018
Figure 06: Global COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 07: Global COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 08: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth, by Inhaler, 2017–2027
Figure 09: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth, by Nebulizer, 2017–2027
Figure 10: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 11: Global COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 12: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Manual Device, 2017–2027
Figure 13: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Digital Device, 2017–2027
Figure 14: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 15: Global COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 16: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2017–2027
Figure 17: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2017–2027
Figure 18: Global COPD Drug Delivery Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2017–2027
Figure 19: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 20: Global COPD Drug Delivery Devices Market Value Share Analysis, by Region, 2018 and 2027
Figure 21: Global COPD Drug Delivery Devices Market Attractiveness Analysis, by Region, 2019–2027
Figure 22: North America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 23: North America COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 24: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 25: North America COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 26: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 27: North America COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 28: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 29: North America COPD Drug Delivery Devices Market Value Share Analysis, by Country, 2018 and 2027
Figure 30: North America COPD Drug Delivery Devices Market Attractiveness Analysis, by Country, 2019–2027
Figure 31: Europe COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 32: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 33: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 34: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 35: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 36: Figure 36: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 37: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 38: Europe COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 39: Europe COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 40: Asia Pacific COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 41: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 42: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 43: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 44: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 45: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 46: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 47: Asia Pacific COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 48: Asia Pacific COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 49: Latin America COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 50: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 51: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 52: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 53: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 54: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 55: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 56: Latin America COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 57: Latin America COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 58: Middle East & Africa COPD Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 59: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Product, 2018 and 2027
Figure 60: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Product, 2019–2027
Figure 61: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Type, 2018 and 2027
Figure 62: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Type, 2019–2027
Figure 63: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 64: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 65: Middle East & Africa COPD Drug Delivery Devices Market Value Share Analysis, by Country/Sub region, 2018 and 2027
Figure 66: Middle East & Africa COPD Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 67: Global COPD Drug Delivery Devices Market Share, by Company, 2018
Figure 68: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 69: AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 70: AstraZeneca Breakdown of Net Sales (%), by Product Segment, 2018
Figure 71: Boehringer Ingelheim International GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 72: Boehringer Ingelheim International GmbH R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Region, 2018
Figure 74: Boehringer Ingelheim International GmbH Breakdown of Net Sales (%), by Business Segment, 2018
Figure 75: GlaxoSmithKline plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 76: GlaxoSmithKline plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 77: GlaxoSmithKline plc Breakdown of Net Sales (%), by Region, 2018
Figure 78: GlaxoSmithKline plc Breakdown of Net Sales (%), by Business Segment, 2018
Figure 79: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 80: Novartis AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 81: Novartis AG Breakdown of Net Sales (%), by Country, 2018
Figure 82: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2018
Figure 83: Teva Pharmaceutical Industries Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 84: Teva Pharmaceutical Industries Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 85: Teva Pharmaceutical Industries Ltd. Breakdown of Net Sales (%), by Segment, 2018
Figure 86: Merck & Co., Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 87: Merck & Co., Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 88: Merck & Co., Inc. Breakdown of Net Sales (%), by Region, 2018
Figure 89: Merck & Co., Inc. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 90: Cipla Inc., Revenue (US$ Mn), 2015–2018
Figure 91: Cipla Inc., Breakdown of Net Sales (%), Therapy-wise, 2018
Figure 92: Cipla Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 93: Sumitomo Dainippon Pharma Co., Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 94: Sumitomo Dainippon Pharma Co., Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 95: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Pharmaceutical Net Sales (%), by Region, 2017
Figure 96: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Net Sales (%), by Product Segment, 2017
Figure 97: Koninklijke Philips N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 98: Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 99: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region, 2018
Figure 100: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 101: Omron Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 102: Omron Corporation (Healthcare Business) R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 103: Omron Corporation (Healthcare Business) Breakdown of Net Sales (%), by Region, 2018
Figure 104: Omron Corporation Breakdown of Net Sales (%), by Business Segment, 2018

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries
  • Merck & Co., Inc.
  • Cipla Inc.
  • Sunovion Pharmaceuticals, Inc.
  • Koninklijke Philips N.V.
  • PARI GmbH
  • Omron Corporation
Note: Product cover images may vary from those shown
Adroll
adroll